Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)
Clinical trial NCT02955589 · COMPLETED
Trial details
- NCT number
- NCT02955589
- Sponsor
- HUYABIO International, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-12-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.